Mostrar el registro sencillo del ítem

dc.contributor.authorPadilla Pérez, M. Carmen
dc.contributor.authorSánchez Fernández, Elena M.
dc.contributor.authorGonzález Bakker, Aday
dc.contributor.authorPuerta, Adrián
dc.contributor.authorMartín Loro, Francisco
dc.contributor.authorGarcía Fernández, José Manuel
dc.contributor.authorPadrón, José M.
dc.contributor.authorArroba Espinosa, Ana Isabel 
dc.contributor.authorOrtiz Mellet, Carmen
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2023-10-18T07:23:14Z
dc.date.available2023-10-18T07:23:14Z
dc.date.issued2023-04-25
dc.identifier.issn0223-5234
dc.identifier.urihttp://hdl.handle.net/10498/29439
dc.description.abstractThe unique electronic properties of the fluorine atom make its strategic incorporation into a bioactive compound a very useful tool in the design of drugs with optimized pharmacological properties. In the field of the carbohydrates, its selective installation at C2 position has proven particularly interesting, some 2-deoxy-2-fluorosugar derivatives being currently in the market. We have now transferred this feature into immunoregulatory glycolipid mimetics that contain a sp2-iminosugar moiety, namely sp2-iminoglycolipids (sp2-IGLs). The synthesis of two epimeric series of 2-deoxy-2-fluoro-sp2-IGLs, structurally related to nojirimycin and mannonojirimycin, has been accomplished by sequential Selectfluor-mediated fluorination and thioglycosidation of sp2-iminoglycals. Exclusively the α-anomer is obtained regardless of the configurational profile of the sp2-IGL (D-gluco or D-manno), highlighting the overwhelming anomeric effect in these prototypes. Notably, the combination of a fluorine atom at C2 and an α-oriented sulfonyl dodecyl lipid moiety in compound 11 led to remarkable anti-proliferative properties, featuring similar GI50 values than the chemotherapy drug Cisplatin against several tumor cell lines and better selectivity. The biochemical data further evidence a strong reduction of the number of tumor cell colonies and apoptosis induction. Mechanistic investigations revealed that this fluoro-sp2-IGL induces the non-canonical activation mode of the mitogen-activated protein kinase signaling pathway, causing p38α autoactivation under an inflammatory context.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceEuropean Journal of Medicinal Chemistry. Vol. 255, July 2023, 115390es_ES
dc.subjectCanceres_ES
dc.subjectFluorinated glycomimeticses_ES
dc.subjectImmunomodulationes_ES
dc.subjectInflammationes_ES
dc.subjectp38α MAPKes_ES
dc.subjectSelectfluores_ES
dc.titleFluoro-labelled sp2-iminoglycolipids with immunomodulatory propertieses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.description.physDesc19 páginases_ES
dc.identifier.doi10.1016/j.ejmech.2023.115390
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-097609-B-C21/ES/VIRUS ARTIFICIALES MEDIANTE SINTESIS DE PRECISION: VECTORES NO-VIRALES MOLECULARES PARE EL TRANSPORTE DE GENES Y FARMACOS/ es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023/PI22%2F01718/ES/La inmunomodulación es una nueva diana terapéutica de la diabetes mellitus tipo 1. Uso de sp2-iminoglicolípidos como tratamientos inspirados en biomoléculas./ es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-105858RB-I00/ES/MIMETICOS DE GLICOCONJUGADOS: NUEVAS ESTRATEGIAS EN GLICOMEDICINA DIRIGIDAS A ENFERMEDADES NEUROLOGICAS Y DEL SISTEMA IMMUNE/ es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICIN/Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023/PID2021-124247OB-C21/ES/TRANSPORTADORES DE ADN/ARN DE NUEVA GENERACION: CAPSIDES MOLECULARES BASADAS EN CARBOHIDRATOS/es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-123059OB-I00es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Andalucia//PI20-01331es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Andalucia/ITIFEDER/PI20-0036es_ES
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internacional